13F-HR filed by Octagon Capital Advisors LP
Octagon Capital Advisors LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 36 holding rows worth $695,013,948.
- Accession
- 0001214659-23-007162
- Filer
- CIK 1839435
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 36 entries on the cover page, a total value of $695,013,948 stated on the cover page (in dollars after the unit check, H1), rows summing to $695,013,948 with VALUE read as dollars as filed, 13F file number 028-20958. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 3,250,000 | $214,370,000 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 2,551,703 | $59,071,924 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 2,468,000 | $49,557,440 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 4,570,918 | $39,858,405 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 2,172,000 | $39,617,280 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,185,000 | $30,146,400 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 3,904,000 | $28,811,520 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 750,000 | $27,885,000 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 759,898 | $27,341,130 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 1,338,160 | $22,186,693 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 474,929 | $19,286,867 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 621,712 | $12,539,931 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871103 | COM | 6,382,500 | $11,552,325 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 495,000 | $11,132,550 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,202,000 | $9,279,440 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 499,996 | $8,594,931 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 596,000 | $8,111,560 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 692,945 | $7,982,726 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 2,425,000 | $7,687,250 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 375,000 | $6,243,750 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 795,000 | $6,169,200 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 400,000 | $6,092,000 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 382,000 | $5,863,700 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 94,700 | $5,128,005 | dollars as filed | |
| GERON CORP | 374163103 | COM | 2,278,000 | $4,943,260 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 577,000 | $4,667,930 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 1,190,000 | $4,581,500 | dollars as filed | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 3,000,000 | $3,780,000 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 420,000 | $2,511,600 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 1,958,069 | $2,467,167 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 93,692 | $2,228,933 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 100,000 | $1,658,000 | dollars as filed | call |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 185,669 | $1,546,623 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 396,000 | $1,524,600 | dollars as filed | |
| VECTIVBIO HLDG AG | H9060V101 | COM | 35,259 | $300,054 | dollars as filed | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 301,490 | $294,254 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-23-007162 | this filing | 2023-05-15 | acceptance time not in the bulk data set |